The importance and merits of greater patient involvement in medicines research and development (R&D) are commonly acknowledged and are thought to offer benefits for all involved parties. It helps to improve discovery, development, and evaluation of new effective medicines, based on the collaborative identification and understanding of unmet needs, research priorities, optimization of clinical study design, outcome measures, and endpoint development. It can result in increased transparency, trust and mutual respect between patients and other stakeholders.
EUPATI Guidance for Patient Involvement in Med... - CLL Support
EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D
Written by
Myrddin
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Stomach and mood disorders: how your gut may be playing with your mind
Vice-Chancellor Research (Acting) and Pro Vice-Chancellor, Faculty of Health and Medicine,...
Introducing Chris Dwyer (Patient Power Video)
Bone\\" where patients connect online to share their stories and research. Through his...
Immunotherapy and Gene Modification of T Cells
new methods under development, and some might be in Clinical Trials. These involve getting the...
Mode of Progression After Frontline Treatment Predicts Clinical Outcomes in Patients With CLL
median overall survival (OS) than fit patients or patients that develop increasing absolute...
Don't know if this info is out there yet, but I just wanted to share
changes that influence the risk of developing CLL. There were 6,200 patients with CLL in this...